Quantitative Advantage’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$2.1M Sell
29,677
-883
-3% -$62.5K 0.31% 66
2022
Q4
$2.08M Sell
30,560
-1,449
-5% -$99K 0.32% 64
2022
Q3
$2M Buy
32,009
+198
+0.6% +$13.6K 0.35% 62
2022
Q2
$2.07M Buy
31,811
+1,767
+6% +$125K 0.36% 53
2022
Q1
$2.32M Buy
30,044
+4,992
+20% +$380K 0.36% 52
2021
Q4
$2.01M Buy
+25,052
New +$1.96M 0.31% 48

Other funds holding AVUS

Quantitative Advantage's AVUS Position: Q1 2023 in Review

Quantitative Advantage reduced its Avantis US Equity ETF (AVUS) stake by 2.9% in Q1 2023, selling an estimated $62.5K and leaving 29,677 shares worth $2.1M. The position accounts for 0.31% of the portfolio, ranked #66.

Quantitative Advantage first reported a position in AVUS in Q4 2021 and has held it in 6 quarters since. The position peaked at $2.32M in Q1 2022. 249 funds tracked by Wall St. Rank hold AVUS as of Q1 2023.

  • Quantitative Advantage held 29,677 shares of Avantis US Equity ETF worth $2.1M as of Q1 2023.
  • Quantitative Advantage sold 883 Avantis US Equity ETF shares in Q1 2023, an estimated $62.5K.
  • Avantis US Equity ETF made up 0.31% of Quantitative Advantage's portfolio in Q1 2023, its #66 holding.
  • Quantitative Advantage first reported a position in Avantis US Equity ETF in Q4 2021 and has held it in 6 quarters since.
  • Quantitative Advantage's Avantis US Equity ETF position peaked at $2.32M in Q1 2022.
  • 249 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q1 2023.

Based on Quantitative Advantage's 13F filing for Q1 2023, filed 12 May 2023.